<DOC>
	<DOCNO>NCT01690884</DOCNO>
	<brief_summary>The investigator try determine single dose Ticagrelor increase delivery intraarterially-infused adenosine forearm interstitium , consistent adenosine reuptake blockade .</brief_summary>
	<brief_title>Effect Ticagrelor vs. Dipyridamole Adenosine Uptake</brief_title>
	<detailed_description>The investigator compare adenosine interstitial level use parallel design study three group subject . Forearm interstitial adenosine level measure baseline intrabrachial infusion adenosine two dos . Subjects randomly receive Ticagrelor 180 mg , Dipyridamole 200 mg , placebo . Two hour later investigator repeat dialysate collection baseline adenosine infusion .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Adenosine</mesh_term>
	<mesh_term>Dipyridamole</mesh_term>
	<mesh_term>Ticagrelor</mesh_term>
	<criteria>1 . Subjects healthy volunteer , without significant pulmonary , cardiovascular gastrointestinal , hematological renal disease 2 . Not take regular medication 3 . Able provide sign consent prior study participation . 1 . History asthma 2 . Pregnancy 3 . Exposure investigational drug last 2 month . 4 . Known hypersensitivity study medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Adenosine</keyword>
	<keyword>Ticagrelor</keyword>
	<keyword>Microdialysis</keyword>
</DOC>